Catheter Precision (VTAK) FCF Margin Growth (3y) (2021 - 2026)
Catheter Precision (VTAK) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -2,196.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2,679.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -20.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -472.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Catheter Precision | 0.80 | -811,999.20 | 390,000.00 | 1.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.36 Mn |
| Jun 30, 2025 | 11.91 Mn |
| Mar 31, 2025 | 9.36 Mn |
| Dec 31, 2024 | 11.21 Mn |
| Sep 30, 2024 | 13.98 Mn |
| Jun 30, 2024 | -122,911.00 |
| Mar 31, 2024 | 20.01 Mn |
| Sep 30, 2023 | 754,978.00 |
| Jun 30, 2023 | -442,301.00 |
| Mar 31, 2023 | -1.37 Mn |
| Jun 30, 2022 | -11.98 Mn |
| Mar 31, 2022 | -9.47 Mn |
| Dec 31, 2021 | -11.36 Mn |
| Sep 30, 2021 | -14.24 Mn |
| Jun 30, 2021 | -37,057.00 |
| Mar 31, 2021 | -20.22 Mn |